|
|
|
|
|
|
Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
ClinicalTrials.gov Identifier: | NCT00000622 |
The purpose of this study is to evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.
Condition | Intervention | Phase |
Asthma Lung Diseases |
Drug: Anti-Asthmatic Agents |
Phase III |
MedlinePlus related topics: | Asthma |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Crossover Assignment |
Official Title: | Childhood Asthma Research and Education (CARE) Network |
Study Start Date: | September 1999 |
Show Detailed Description |
Ages Eligible for Study: | up to 18 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
United States, Arizona | |||||
University of Arizona | |||||
Tucson, Arizona, United States, 85724 | |||||
United States, California | |||||
University of California, San Diego | |||||
La Jolla, California, United States, 92093-0833 | |||||
United States, Colorado | |||||
National Jewish Medical and Research Center | |||||
Denver, Colorado, United States, 80206 | |||||
United States, Missouri | |||||
Washington University | |||||
St. Louis, Missouri, United States, 63110 | |||||
United States, Wisconsin | |||||
University of Wisconsin | |||||
Madison, Wisconsin, United States, 53792-4108 |
Related Info 
  |
Study ID Numbers: | 219, U10 HL64287, U10 HL64288, U10 HL64295, U10 HL64305, U10 HL64307, U10 HL64313 |
First Received: | October 27, 1999 |
Last Updated: | August 24, 2006 |
ClinicalTrials.gov Identifier: | NCT00000622 |
Health Authority: | United States: Federal Government |
|
|
|